Piramal Pharma Limited
Piramal Pharma Limited, a prominent player in the global pharmaceutical industry, is headquartered in India and operates extensively across key regions, including North America, Europe, and Asia. Founded in 1988, the company has achieved significant milestones, establishing itself as a leader in both contract development and manufacturing, as well as in the formulation of complex generics.
Piramal Pharma's core offerings include a diverse range of pharmaceutical products and services, with a strong emphasis on innovative drug delivery systems and advanced therapies. Their commitment to quality and sustainability sets them apart in a competitive market. With a robust portfolio and a focus on research and development, Piramal Pharma Limited continues to enhance its market position, contributing to healthcare solutions worldwide.
+41 vs industry average
Piramal Pharma Limited’s score of 79 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Piramal Pharma Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Piramal Pharma Limited's reported carbon emissions
In 2025, Piramal Pharma Limited reported total carbon emissions of approximately 618.5 million kg CO2e. This figure includes Scope 1 emissions of about 32.3 million kg CO2e, Scope 2 emissions of approximately 66.1 million kg CO2e, and Scope 3 emissions amounting to about 491.1 million kg CO2e. The company has set ambitious targets to reduce its greenhouse gas emissions, committing to a 42% reduction in absolute Scope 1 and Scope 2 emissions by FY2030, using FY2022 as the baseline. Additionally, Piramal aims for a 25% reduction in absolute Scope 3 emissions within the same timeframe. Piramal Pharma Limited has applied for the Science Based Targets initiative (SBTi) to align its emissions reduction goals with the 1.5°C decarbonisation pathway. The targets encompass emissions from purchased goods and services, fuel and energy-related activities, upstream transportation and distribution, and the use of sold products. These commitments reflect the company's dedication to sustainability and its proactive approach to addressing climate change.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Piramal Pharma Limited’s Climate Goals (2030 & 2050)
1 goal2030
42% reduction in Scope 2
Reduce Scope 1 and Scope 2 emissions by 42% by FY 2030 (with baseline of FY 2022), which aligns with the 1.5°C decarbonization pathway as re…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 1 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
13 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Piramal Pharma Limited’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project